CGIX up +16.50% percent right now. $CGIX High is at 7.94

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 2:46 PM

CGIX up +16.50% percent right now. $CGIX High is at 7.94 and the Low 6.76 with current volume of 171,103.

Recent News posted below.

CGIX Cancer Genetics Inc Recent Headline News

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - 1 hr 45 mins ago

UCP: 11.90 (-1.89), JRJC: 6.24 (+0.73), NAVB: 1.03 (-0.19), SANW: 3.79 (+0.71), PLPM: 1.63 (+0.26), RYN: 28.80 (-5.10), INFU: 3.00 (-0.49), LIOX: 5.46 (+0.72), DY: 27.75 (-3.12), MTZ: 25.16 (-3.47), CGIX: 6.92 (+0.92), MUX: 1.25 (-0.16), OREX: 5.11 (+1.26), URRE: 2.59 (+0.65), ACHN: 12.56 (+2.45), REN: 2.83 (-0.78), MPO: 3.34 (+0.23), AKBA: 9.38 (-1.32), TRX: 1.02 (-0.20), PLNR: 7.53 (+1.13)

Cancer Genetics' (CGIX) CEO Panna Sharma on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - 2 hrs 17 mins ago

CGIX: 6.92 (+0.92)

Cancer Genetics ups revenues 88% in Q3
Seeking Alpha - at Seeking Alpha - 2 hrs 42 mins ago

CGIX: 6.92 (+0.92)

Cancer Genetics Announces Strong Third Quarter With Growth Across All Categories
GlobeNewswire - Mon Nov 10, 7:43AM CST
Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, announced today financial and operating results for the third quarter ended September 30, 2014.
CGIX: 6.92 (+0.92)

Cancer Genetics beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:58AM CST

CGIX: 6.92 (+0.92)

Cancer Genetics, Inc. to Report Third Quarter 2014 Financial Results on Monday, November 10
GlobeNewswire - Thu Oct 30, 7:30AM CDT
Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, announced today that it will report third quarter 2014 financial results on Monday, November 10, 2014. The Company will issue a press release before the market opens and will host a conference call at 8:30am Eastern Standard Time to discuss the third quarter financial results and to answer questions.
CGIX: 6.92 (+0.92)

Cancer Genetics Inc. Granted Patent for Genomic Probe Set Used in Proprietary Test for Cervical and Other HPV-Associated Cancers
GlobeNewswire - Tue Oct 21, 6:59AM CDT
> Issuance of patent 8,865,882 covers four probe set used in CGI's proprietary FISH-based HPV-Associated Cancer Test (FHACT(R))
CGIX: 6.92 (+0.92)

Cancer Genetics Inc. Announces Collaboration With Leading Oncology Researchers at Columbia University to Identify Genomic Signatures, Biomarkers and Novel Treatments for MDS and AML
GlobeNewswire - Mon Oct 13, 6:45AM CDT
> The collaboration will result in a novel, next-generation sequencing based panel for the improved diagnosis and prognosis of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
CGIX: 6.92 (+0.92)

Global Genetic Testing Market - Industry Analysis And Market Forecast 2014-2020
PR Newswire - Thu Oct 09, 2:50PM CDT
Genetic testing is the analysis of genes, chromosomes, or proteins to help predict the risk of disease, identify carriers (individuals who do not have the disease but have a copy of the disease gene) of disease, diagnose disease, or determine the likely course of a disease. Cytogenetics, Molecular Genetics, Cancer Genetics, Prenatal Screening and Prenatal diagnosis are type of genetic tests that involves examining a person's genetic material taken from cells in a sample of blood or, occasionally, from other body fluids or tissues.
CGIX: 6.92 (+0.92)

Cancer Genetics Inc. to Provide Updates About the Company's Portfolio of Targeted Molecular Diagnostics at Analyst Day on September 25, 2014
GlobeNewswire - Wed Sep 24, 6:45AM CDT
Cancer Genetics Inc. (Nasdaq:CGIX) ("CGI" or "the Company"

, an emerging leader in DNA-based cancer diagnostics, today released an agenda for its upcoming Analyst Day, to be held Thursday, September 25 in Raleigh, North Carolina.
CGIX: 6.92 (+0.92)

Cancer Genetics, Inc. and Beth Israel Deaconess Medical Center Enter Into Collaboration to Correlate Genomic Profiles to Patient Outcome in Diffuse Large B-Cell Lymphoma
GlobeNewswire - Tue Sep 23, 6:45AM CDT
-- Study will correlate genetic markers to outcome in ~200 patients with diffuse large B-cell lymphoma (DLBCL), the most common form of non-Hodgkin lymphoma.
CGIX: 6.92 (+0.92)

Cancer Genetics, Inc. to Present at Aegis Healthcare and Technology Conference on Thursday, September 11, 2014
GlobeNewswire - Wed Sep 10, 6:59AM CDT
Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"

, an emerging leader in DNA-based cancer diagnostics, announced today that Panna Sharma will present at the Aegis Healthcare and Technology Conference on Thursday, September 11, 2014 at 8:30 am Pacific Daylight Time (11:30 am EDT).
CGIX: 6.92 (+0.92)

Cancer Genetics' Proprietary IVD for Cervical Cancer, FHACT(R), Receives CE
GlobeNewswire - Tue Sep 02, 7:15AM CDT
- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"

, an emerging leader in DNA-based cancer diagnostics, announced today that their proprietary DNA-probe based test for cervical cancer (FHACT(R)) has received the CE Marking.
CGIX: 6.92 (+0.92)

Cancer Genetics' Proprietary Genomic Diagnostic Tests Added to National Institutes of Health's Genetic Testing Registry
GlobeNewswire - Wed Aug 27, 6:59AM CDT
-- Online database allows clinicians and patients to search for genetic and genomic tests by disease state
CGIX: 6.92 (+0.92)

Cancer Genetics, Inc. and Leading Pathologist From Keck Medicine of USC Collaborate to Evaluate and Optimize Genomic Panel for Lymphoma
GlobeNewswire - Mon Aug 25, 7:30AM CDT
-- Collaboration will identify and evaluate new genomic markers for most common form of non-Hodgkin's lymphoma
CGIX: 6.92 (+0.92)

Cancer Genetics Inc. Completes Acquisition of BioServe India, a Premier Genomics and Next-Generation Sequencing Company
GlobeNewswire - Sun Aug 17, 11:00PM CDT
-- Cancer Genetics Now Positioned to Participate in High-Growth Indian Diagnostics Market, Where More Than 1 Million New Cancer Cases Are Diagnosed Each Year
CGIX: 6.92 (+0.92)

Cancer Genetics Reports Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 14, 6:05AM CDT
Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, announced today financial results for the second quarter and six months ended June 30, 2014.
CGIX: 6.92 (+0.92)

BioNano Genomics Announces The Purchase Of The Irys System By The Wellcome Trust Sanger Institute
PR Newswire - Tue Aug 12, 7:00AM CDT
BioNano Genomics announced today the purchase of an IrysTM System by the Wellcome Trust Sanger Institute, one of the world's leading genome centers, located near Cambridge, UK. The Sanger Institute made the largest single contribution to the gold standard sequence for the Human Genome Project and today is focused on the role of genetics in health and disease. The Sanger Institute purchased BioNano's Irys platform to detect structural variation and complete genomes for various projects including the Cancer Genomics Project, which seeks to develop new ways of detecting rearrangements in cancer samples, and the Parasite Genomics Team, which is sequencing the genomes of parasites that cause malaria and neglected tropical diseases prevalent in the developing world.
CGIX: 6.92 (+0.92)

Cancer Genetics to Report Second Quarter 2014 Financial Results on Thursday, August 14, 2014
GlobeNewswire - Fri Aug 08, 7:56AM CDT
Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, announced today that it will report second quarter 2014 financial results on Thursday, August 14, 2014. The Company will issue a press release before the market opens and will host a conference call at 8:30am Eastern Time to discuss the second quarter financial results, the closing of the Gentris acquisition, the proposed FDA regulatory framework, and to answer questions.
CGIX: 6.92 (+0.92)

RedChip Issues Research Update on Cancer Genetics
GlobeNewswire - Thu Aug 07, 11:09AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers.
CGIX: 6.92 (+0.92)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 AI Talent Study Reveals Growth and Gaps

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

TECNO Unleashes New Laptops & Phones at IFA 2026

A Bold Leap by TECNO You walk into the IFA ShowStoppers 2026 event, and what’s greeting you is a flashy splash of next-gen tech from TECNO. Now, if you thought this brand was only about pushing phones, you're in for a ride. TECNO has crashed the laptop party with its new MEGABOOK T15 360 Series, showing it’s more than capable of straddling the tablet and laptop worlds...

Luxury Air Celebrates 18 Years of Comfort Service

Celebrating 18 Years: A Journey of Comfort It's not often you see a business weave itself so seamlessly into the fabric of its community. But that's exactly what Luxury Air A/C & Heating has done in Conroe, The Woodlands, and across Montgomery County. Hit 18 years in the HVAC game, and you've clearly nailed something other folks can't quite replicate. Guess there's no...

Proxet’s IDLC Model Transforms AI Software Delivery

Revolutionizing AI Software with a New Approach If there's one thing the tech industry loves, it's a fresh model promising to streamline project chaos into well-oiled machinery. Enter Proxet with what they're calling the IDLC model—that's Intent-Driven Lifecycle. It's aimed straight at the creaky old way companies have been handling AI and software projects. The idea is...

Safety and Wellbeing as Key Business Strategy Focus

Revolutionizing Safety in the Workplace Cracking the typical mindset of treating employee safety as a checkbox item, Debra Wein, CEO and Founder of Wellness Workdays, is set to shake up the NSC Safety Congress & Expo. Her upcoming session, titled "Transforming Safety and Wellbeing into a Competitive Business Advantage," isn't just a run-of-the-mill talk. It's a call to...

Courtesy Auto Group Expands with Tucson Dealerships Buy

Moving Pieces in the Automotive Puzzle Here's one for the books, folks. Automotive dealership chessboard gets another shuffle. Scott Gruwell, the big wheel behind Courtesy Automotive Group, has snatched up Watson Chevrolet and Infiniti of Tucson. Just one more notch in someone's power belt—operations now rolling under new banners as Courtesy Chevrolet and Courtesy...

Greenberg Traurig Shines in 2026 Palm Beach Attorney List

Legal Eagles Soar in the Sunshine State Right out of the gate, it looks like Greenberg Traurig's West Palm Beach office is getting all the spotlight. Twenty-one of their legal hotshots have clinched spots on Palm Beach Illustrated's 2026 'Top Lawyers' list. For those keeping score, that's a hefty nod in this competitive market. A Closer Look at the Selection Process Now,...

Restaurant Industry Bolsters Safety with New Guide

There’s a fresh playbook hitting the shelves, and it’s aimed at the heart of the dining world—a guide that tackles the nasty curveballs of public safety incidents. Restaurants, the places we count on for warm meals and cold drinks, aren’t just about what’s on the menu; they're about keeping folks safe, too. The National Restaurant Association just dropped a new...

Hartford Students Get Boost from Hygiene Initiatives

Beyond Backpacks: Essential Hygiene for Hartford Kids When September rolls around, it’s not just about those shiny new backpacks and unopened notebooks. In good ol’ Hartford, some students find themselves in need of basics that get overlooked—a stick of deodorant, a bar of soap, maybe some period products. Skimp on these, and all of a sudden, showing up for school...

California American Water’s $8.6M Project: Big Move Upfront

California's Lincoln Oaks neighborhood is gearing up for some necessary upheaval, thanks to California American Water’s new $8.6 million infrastructure overhaul. For decades, those folks in Sylvan Park have been juggling with the roulette of aging water mains in their backyards. Now, imagine that: backyard pipes begging to turn traitors. It's about time someone decided...